New injection aims to stop dangerous bleeds in Tough-to-Treat hemophilia
NCT ID NCT06312475
Summary
This study is testing whether regular injections of an experimental drug called KN057 can safely prevent bleeding episodes in people with hemophilia A or B who have developed inhibitors. Participants are randomly assigned to receive either KN057 injections for a year or start with standard on-demand treatment before switching to KN057. The main goal is to see if KN057 reduces the yearly rate of bleeds that need treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A WITH INHIBITOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, 300020, China
Conditions
Explore the condition pages connected to this study.